CD68 and COVID-19: Similarly, postmortem analyses of COVID-19 patients have revealed increased numbers of CD68+ macrophages in the lungs (Barbosa et al., 2022; Cao et al., 2022), and their activation has been implicated in pulmonary tissue damage (Ziablitsev et al., 2023).